azelaprag tirzepatide BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics Azelaprag (AMG986) + Tirzepatide Combination
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8





















